Primary osteoporosis in postmenopausal women

Código QR

Primary osteoporosis in postmenopausal women

Guardado en:

Detalles Bibliográficos
Autores principales:	Meng-Xia Ji, Qi Yu
Formato:	article
Lenguaje:	EN
Publicado:	KeAi Communications Co., Ltd. 2015
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/feec420f7b4e46d7a8ed55a937fd4dd0
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Denosumab: an investigational drug for the management of postmenopausal osteoporosis
por: E Michael Lewiecki
Publicado: (2008)

WGCNA Identification of Genes and Pathways Involved in the Pathogenesis of Postmenopausal Osteoporosis
por: Hao ML, et al.
Publicado: (2021)

Early Changes of VEGF Levels After Zoledronic Acid in Women With Postmenopausal Osteoporosis: A Potential Role of Vitamin D
por: Federica Bellone, et al.
Publicado: (2021)

Alendronate improves QOL of postmenopausal women with osteoporosis
por: Hisaya Kawate, et al.
Publicado: (2010)

Association between periodontal disease and osteoporosis in postmenopausal women: a protocol for systematic review and meta-analysis
por: Jing Qi, et al.
Publicado: (2021)

ASSESSMENT OF RADIOMORPHOMETRIC AND RADIOMORPHOLOGIC INDICES IN POSTMENOPAUSAL WOMEN
por: SH Sakhdari,, et al.
Publicado: (2006)

The importance of the UGT1A1 variants in the development of osteopenia and osteoporosis in postmenopausal women
por: Anna Bogacz, et al.
Publicado: (2021)

Denosumab versus romosozumab for postmenopausal osteoporosis treatment
por: Tomonori Kobayakawa, et al.
Publicado: (2021)

Quarterly intravenous injection of ibandronate to treat osteoporosis in postmenopausal women
por: Philip Sambrook
Publicado: (2007)

Cost-effectiveness of Osteoporosis Screening in Women over 40 Years old
por: Nahid Hatam, et al.
Publicado: (2021)

Serum interleukin-17 and estradiol levels in postmenopausal women in relation to osteoporosis
por: Reem El-Mallah, et al.
Publicado: (2021)

Effect of Regular Aerobic Exercise on Vasomotor Symptoms (Hot Flashes) in Postmenopausal Women
por: B Tartibian, et al.
Publicado: (2009)

Efficacy and safety of bazedoxifene for postmenopausal osteoporosis
por: Kawate H, et al.
Publicado: (2011)

Menopausal Symptoms among Postmenopausal Women of a Selected Municipality: A Cross-sectional Survey
por: Sitasma Sharma, et al.
Publicado: (2021)

Health-related quality of life in Romanian postmenopausal women with osteoporosis and fragility fractures
por: Ciubean AD, et al.
Publicado: (2018)

The Pattern of Second Primary Tumours in Postmenopausal Women with Prior Breast Cancer in Western Romania: A Retrospective, Single-Institution Study
por: Cristina Marinela Oprean, et al.
Publicado: (2021)

A STUDY OF THE POTENCY OF PIPELLE BIOPSY TECHNIQUE TO DETECT ENDOMETRIAL DISEASE IN PERIMENOPAUSAL / POSTMENOPAUSAL WOMEN
por: Nabila Amin, et al.
Publicado: (2020)

BFH-OST, a new predictive screening tool for identifying osteoporosis in postmenopausal Han Chinese women
por: Ma Z, et al.
Publicado: (2016)

Prevalence and Risk Factors of Osteoporosis in Chinese Postmenopausal Women Awaiting Total Knee Arthroplasty
por: Tao Y, et al.
Publicado: (2021)

Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene
por: Luigi Gennari, et al.
Publicado: (2010)

Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia)
por: Fujiwara S, et al.
Publicado: (2014)

Full length parathyroid hormone (1–84) in the treatment of osteoporosis in postmenopausal women
por: Esteban Jódar-Gimeno
Publicado: (2007)

Hip fracture protection by alendronate treatment in postmenopausal women with osteoporosis: a review of the literature
por: Jun Iwamoto, et al.
Publicado: (2008)

Assessment of the Elastographic and Electromyographic of Pelvic Floor Muscles in Postmenopausal Women with Stress Urinary Incontinence Symptoms
por: Kuba Ptaszkowski, et al.
Publicado: (2021)

The predictive role of monocyte-lymphocyte ratio and plateletlymphocyte ratio in postmenopausal osteoporosis
por: Ibrahim Kale
Publicado: (2021)

Short-range UV-LED irradiation in postmenopausal osteoporosis using ovariectomized mice
por: Satoshi Ochiai, et al.
Publicado: (2021)

Emerging treatments for postmenopausal osteoporosis – focus on denosumab
por: Piet Geusens
Publicado: (2009)

POSTMENOPAUSAL BLEEDING - A STRONG INDICATOR OF ENDOMETRIAL CARCINOMA
por: Saima Jadoon, et al.
Publicado: (2019)

Efficacy and Safety of Oral Ibandronate versus Intravenous Zoledronic Acid on Bone Metabolism and Bone Mineral Density in Postmenopausal Japanese Women with Osteoporosis
por: Masashi Uehara, et al.
Publicado: (2021)

Experimental Modeling of Osteoporosis in Animals
por: N.V. Dedukh, et al.
Publicado: (2021)

Relationships between serum Omentin-1 levels and bone mineral density in older men with osteoporosis
por: Li Yang, et al.
Publicado: (2016)

The epidemiology and management of postmenopausal osteoporosis: a viewpoint from Brazil
por: Baccaro LF, et al.
Publicado: (2015)

Is grand multiparity a risk factor for the development of postmenopausal osteoporosis?
por: Peker N, et al.
Publicado: (2018)

Liposomal formulation of vitamin A for the potential treatment of osteoporosis
por: Sachaniya J, et al.
Publicado: (2018)

Transient osteoporosis of the hip: Physicians the occupation of at risk
por: Abolfazl Fattah, et al.
Publicado: (2021)

Hormonal Approach for Postmenopausal Vulvovaginal Atrophy
por: Ana Paula Ferreira Costa, et al.
Publicado: (2021)

Retraction Note: Associations between VDR Gene Polymorphisms and Osteoporosis Risk and Bone Mineral Density in Postmenopausal Women: A systematic review and Meta-Analysis
por: Liang Zhang, et al.
Publicado: (2021)

New advances in the diagnosis of primary aldosteronism
por: Hang Shen, et al.
Publicado: (2020)

Postmenopausal Chinese-Singaporean Women Have a Higher Ratio of Visceral to Subcutaneous Adipose Tissue Volume than Caucasian Women of the Same Age and BMI
por: Maria Kalimeri, et al.
Publicado: (2021)

Integrative Bone Metabolomics—Lipidomics Strategy for Pathological Mechanism of Postmenopausal Osteoporosis Mouse Model
por: Hongxia Zhao, et al.
Publicado: (2018)